| Company | Designation | Period |
|---|---|---|
| Emcure | Sr Vice President | Oct 2003 – Mar 2008 |
| Farmalider S A | Chief Business Officer & Director - Corporate Strategy | Nov 2011 – Apr 2014 |
| Emcure Pharmaceuticals Limited | President - Business Strategy and Specialty Business | May 2014 – May 2019 |
| Cantabria Pharma | Managing Director | Mar 2008 – Oct 2011 |
| Zydus Cadila | Vice President | Jan 2000 – Jan 2002 |
| Cadila Pharmaceuticals | General Manager | Jan 1997 – Jan 2000 |
| allergan | National Sales and Marketing Manager | Jan 1994 – Jan 1997 |
| Ranbaxy | Marketing Manager | Jan 1991 – Jan 1994 |
| Parke Davis | Associate Director | Jan 1989 – Jan 1991 |
| Warner Hindustan | Associate Director | Jan 1985 – Jan 1991 |
| Cibeles Pharmaceuticals | Founder , CEO | Nov 2019 – Present |
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Official Email: Via Cibeles Pharmaceuticals Private Limited corporate communication desk.
Personal Contact: Not publicly disclosed.
What is Sainath Iyer's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Cibeles Pharmaceuticals Private Limited's official communication channels.
Is this an official profile?
No — independently created using public data.
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)